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Purpose: The impacts of different time courses and the degree of neointimal 
growth on neointimal morphology have not yet been sufficiently investigated. 
Therefore, we evaluated the morphological features of neointimal tissue after 
drug-eluting stent (DES) implantation using optical coherence tomography (OCT). 
Materials and Methods: The morphological features of neointimal tissue in stent-
ed segments with a maximal percentage of cross-sectional area (CSA) stenosis of 
neointima were evaluated in 507 DES-treated lesions with >100 μm mean neointi-
mal thickness on follow-up OCT. Neointimal tissue was categorized as homoge-
neous, heterogeneous, layered, or neoatherosclerotic. Results: In lesions with 
<50% of neointimal CSA stenosis, homogeneous neointima (68.2%) was predom-
inant, followed by heterogeneous neointima (14.1%) and layered neointima 
(14.1%). In lesions with ≥50% of neointimal CSA stenosis, layered neointima was 
most frequently observed (68.3%), followed by neoatherosclerotic neointima 
(25.2%). In subgroup analysis of lesions with ≥50% of neointimal CSA stenosis, 
89.5% of the lesions with a stent age <30 months were layered neointima, while 
62.3% of the lesions with a stent age ≥30 months were neoatherosclerotic neointi-
ma. Conclusion: This study suggests that the OCT-detected morphology of DES 
neointimal tissue was different according to the follow-up time course and degree 
of neointimal hyperplasia.
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INTRODUCTION
Optical coherence tomography (OCT) is able to provide the characterization of 
neointimal tissue and differentiate the various types of neointimal tissue that exist 
inside coronary stents.1,2 In addition, OCT revealed that neoatherosclerosis was 
the common mechanism of very late drug-eluting stent (DES) failure.3,4 Using 
OCT, we previously reported that the morphologic characteristics of neointimal 
tissues of DES restenotic lesions were different from those of non-restenotic le-
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OCT procedure and analysis
OCT was performed with either the Model M2 imaging 
system or the C7-XRTM imaging systems (LightLab Imag-
ing, Inc., St. Jude Medical, St. Paul, MN, USA). In the Mod-
el M2, the occlusion catheter was positioned proximal to the 
stent and a 0.014-inch wire-type imaging catheter was posi-
tioned distal to the stent. During image acquisition, the occlu-
sion balloon (Helios, Avantec Vascular Corp., Sunnyvale, 
CA, USA) was inflated to 0.4 to 0.6 atm; lactated Ringer’s 
solution was infused at 0.5 to 1.0 mL/s. The imaging wire 
was pulled from distal to proximal with a motorized pull-
back system at 1.0 mm/s.8 The frequency-domain OCT sys-
tem (Model C7-XRTM) was developed to generate frames at 
much higher rates, thus allowing faster pullback speeds. 
OCT images were generated at a rotational speed of 100 
frames/s, while a catheter was pulled back at 20 mm/s. A 
non-occlusive contrast medium was continuously flushed 
through a guiding catheter at a rate of 4 to 5 mL/s for 3 to 4 
seconds. With both systems, continuous images were ac-
quired and stored digitally for subsequent analysis.
All OCT images were analyzed at a core laboratory (Car-
diovascular Research Center, Seoul, Korea) by analysts who 
were blinded to patient and procedural information. Cross-
sectional OCT images were analyzed at 1-mm intervals for 
quantitative measurements and qualitative analysis in five 
consecutive cross-sections with a maximal percentage of 
CSA stenosis of neointima: (neointimal CSA/stent CSA)× 
100. Stent and luminal CSA were measured, and neointimal 
CSA was calculated as the stent CSA minus the luminal 
CSA. The stented segments with the maximal percentage of 
neointimal CSA stenosis were then assessed qualitatively to 
characterize neointimal tissue as 1) homogeneous neointi-
ma, an uniform signal-rich band without focal variation or 
attenuation; 2) heterogeneous neointima, focally changing 
optical properties and various backscattering patterns; 3) 
layered neointima, layers with different optical properties, 
namely an adluminal high scattering layer and an abluminal 
low scattering layer; and 4) neoatherosclerotic neointima, 
lipid-laden neointima, thin-cap fibroatheroma-like neointi-
ma, or neointima with calcification (Fig. 1).1,7,9 Lipid-laden 
neointima was defined as a signal-poor region with diffuse 
borders, and neointima with calcification was defined as a 
well-delineated, signal-poor region with sharp borders.9 To 
distinguish layered neointima from lipid-laden neointima, 
we considered a signal-poor region that fully masked the 
stent struts behind the neointima to be a lipid-laden neointi-
ma. A thin-cap fibroatheroma-like neointima was defined as 
sions.5 However, detailed information about the character 
of neointimal tissues is still insufficient because previous 
OCT studies were performed with relatively small study 
population.4-7 In the present study, therefore, we investigat-
ed the morphological features of neointimal tissue in a 
larger study population that had both a wide range of reste-
notic lesions and extended follow-up periods after DES 
implantation.
MATERIALS AND METHODS
　　　
Study design
A total of 1289 DESs were evaluated by follow-up OCT 
between September 2007 to July 2012. After the maximal 
percentage of cross-sectional area (CSA) stenosis was de-
termined by OCT, five consecutive images of cross-sec-
tions at 1 mm intervals were identified. Among 1289 DESs, 
725 DESs had ≤100 μm of mean neointimal thickness; oth-
er 57 DESs were excluded for poor quality of OCT images, 
totally occluded in-stent restenosis, or stent thrombosis. 
Thus, 507 DESs (418 patients) with >100 μm mean neo-
intimal thickness were finally enrolled from the OCT regis-
try database of our institute. The reasons for follow-up an-
giography were: 1) evaluation for myocardial ischemia (72 
patients); or 2) planned angiography for itself or other seg-
ments (346 patients). General inclusion and exclusion crite-
ria of the follow-up OCT procedures have been previously 
reported.8 
The selection of DES at the time of coronary intervention 
was at the physician’s discretion. Patients were treated with 
117 sirolimus-eluting stents (Cypher®, Cordis, Miami Lakes, 
FL, USA), 102 paclitaxel-eluting stents (Taxus®, Boston Sci-
entific, Natick, MA, USA), 204 zotarolimus-eluting stents 
(Endeavor sprint® or Resolute®, Medtronic, Santa Rosa, 
CA, USA), 67 everolimus-eluting stents (Xience®, Abbott 
Vascular, Abott Park, IL, USA), and 17 biolimus-eluting 
stents (Nobori®, Terumo Corporation, Tokyo, Japan). 
Stent implantation was performed using conventional 
techniques. Unfractionated heparin was administered as an 
initial bolus of 100 IU/kg, with additional boluses adminis-
tered during the procedure to achieve an activated clotting 
time of 250 to 300 seconds. Dual anti-platelet therapy (as-
pirin and clopidogrel) was recommended to all patients for 
at least 12 months. This study was approved by the Institu-
tional Review Board of our institute, and written informed 
consent was obtained from each patient.
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Statistical analysis
Statistical analysis was performed using PASW (version 
18.0.0, SPSS Inc., Chicago, IL, USA). Data were expressed 
as number (%) or mean±standard deviation. Comparisons of 
categorical data were made using χ-square statistics or Fish-
er’s exact test. Continuous variables were compared using 
Student’s t-test or Mann-Whitney test. Multivariate logistic 
regression model was used to determine independent risk 
factors for neoatherosclerotic neointima. Variables with a p-
value <0.1 in univariate analysis were entered into the mul-
tivariate analysis. A p value <0.05 was considered statisti-
cally significant.
 
RESULTS
 
There were no significant differences in the baseline clinical 
characteristics between the patients with ≥50% and <50% 
neointima with a fibrous cap thickness of ≤65 μm at the 
thinnest part and an angle of lipid-laden neointima ≥180°.7,9 
Because the optimal cut-off time to predict neoatheroscle-
rosis in DES-treated lesions was 30 months in our previous 
study,10 subgroup analysis of neointimal lesions with ≥50% 
of CSA stenosis and a stent age of either ≥30 or <30 months 
was performed. The inter- and intra-observer agreements 
for assessing neointimal tissue morphology in our laborato-
ry were previously reported.5
Quantitative angiographic analysis
Quantitative coronary angiography analysis was performed 
using an offline computerized quantitative coronary angio-
graphic system (CASS system, Pie Medical Imaging, Maas-
tricht, the Netherlands). The minimal lumen diameter of 
treated coronary lesions and reference diameter at post-in-
tervention and follow-up were measured in the view that 
was the narrowest and not foreshortened. 
Fig. 1. Representative optical coherence tomographic images of neointimal tissue. (A) Homogeneous type. (B) Heterogeneous type. (C) 
Layered type. (D) Neoatherosclerotic type.
A
C
B
D
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than those without (75.0% vs. 93.5%, p<0.001) (Table 5). 
However, multivariate analysis showed that stent age was 
an independent predictor for neoatherosclerotic neointima 
(odds ratio, 1.130; 95% confidence interval, 1.092--1.170; 
p<0.001). 
DISCUSSION
This OCT study demonstrates that the morphological pat-
tern of neointimal tissue after DES implantation depends 
both on the burden of neointimal hyperplasia and stent age. 
Homogeneous neointima was the most common morpholo-
gy type in lesions with <50% of neointimal CSA stenosis. 
In contrast, in lesions with ≥50% of neointimal CSA steno-
sis, layered and neoatherosclerotic neointima were frequent-
ly detected. While layered neointima was largely attribut-
able to in-stent restenotic lesions in lesions with a stent age 
<30 months, neoatherosclerotic neointima contributed to 
neointimal growth in DESs ≥30 months after implantation. 
Layered neointima was the dominant morphology type in 
patients with stable angina, whereas neoatherosclerotic 
neointima was in patients with acute coronary syndrome. 
The early vascular reaction after bare metal stent implanta-
tion is thrombus formation and acute inflammation around 
the strut, followed by neointimal growth.11 In the early phase 
after stenting, fibrin, platelet, and inflammatory cells are 
nearly always observed in association with stent struts. They 
gradually disappear, as spindle-shaped mesenchymal cells 
(α-actin-positive smooth muscle cells) form a neointima 
within the proteoglycan matrix associated with the stent 
struts.11 Although it is known that in-stent restenosis arises 
from the overwhelming growth of neointima, few patho-
logic studies have reported the detailed components of re-
neointimal CSA stenosis (Table 1). Coronary angiographic 
findings are presented in Table 2. In lesions with ≥50% of 
neointimal CSA stenosis, the intervention of the left circum-
flex artery and use of new-generation DESs, such as zotaro-
limus- or everolimus-eluting stent, were less frequently ob-
served. Furthermore, in this group, the stent diameter was 
larger and the stent length was longer. OCT findings be-
tween the two groups are shown in Table 2. Time interval 
after index procedure was longer in lesions with ≥50% of 
neointimal CSA stenosis. The morphologic features of the 
neointimal tissue according to the percentage of neointimal 
CSA stenosis (Fig. 2A) and time intervals of OCT after in-
dex procedure (Fig. 2B) are presented in Table 2. In lesions 
with <50% of neointimal CSA stenosis, homogeneous neo-
intima (68.2%) was the predominant morphology, followed 
by heterogeneous neointima (14.1%), and layered neointi-
ma (14.1%). In lesions with ≥50% of neointimal CSA steno-
sis, layered neointima was the most frequently observed 
morphology (68.3%), followed by neoatherosclerotic neo-
intima (25.2%). In a subgroup analysis of lesions with >50% 
of neointimal CSA stenosis, the predominant morphology 
of the neointimal tissue was different according to the stent 
age. In lesions with a stent age <30 months, layered neo-
intima morphology (89.5%) was most frequently observed, 
while neoatherosclerotic neointima (62.3%) morphology 
was predominant in lesions with a stent age ≥30 months 
(Table 2, Fig. 3). While layered neointima was most fre-
quently detected (70.4%) in patients with stable angina, 
neoatherosclerotic neointima was most common (71.4%) in 
patients with acute coronary syndrome (Table 3). The fre-
quency of neoatherosclerotic neointima was higher in first-
generation DES than in new-generation DES (20.5% vs. 
1.0%, p<0.001) (Table 4). Also, the frequency of statin us-
age was lower in lesions with neoatherosclerotic neointima 
Table 1. Baseline Clinical Characteristics
<50% CSA stenosis (n=288) ≥50% CSA stenosis (n=130) p value
Age (yrs) 61.7±8.8 62.9±9.8 0.217
Male 191 (66.3) 93 (71.5) 0.290
Diabetes mellitus   90 (31.3) 49 (37.7) 0.196
Hypertension 168 (58.3) 81 (62.3) 0.443
Hypercholesterolemia 112 (38.9) 60 (46.2) 0.162
Current smoker   51 (17.7) 32 (24.6) 0.101
Clinical diagnosis 0.677
    Stable angina 216 (75.0) 95 (73.1)
    Acute coronary syndrome   72 (25.0) 35 (26.9)
CSA, cross-sectional area.
Data are presented as mean±SD or n (%). 
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Table 2. Coronary Angiographic and Optical Coherence Tomographic Findings
Coronary angiography <50% CSA stenosis (n=368) ≥50% CSA stenosis (n=139) p value
Target lesions   0.004
    Left anterior descending artery 183 (49.7)   85 (61.2)
    Left circumflex artery   77 (20.9) 12 (8.6)
    Right coronary artery 108 (29.3)   42 (30.2)
Type of drug-eluting stent   0.006
    Sirolimus-eluting stent   83 (22.6)   34 (24.5)
    Paclitaxel-eluting stent   63 (17.1)   39 (28.1)
    Zotarolimus-eluting stent 155 (42.1)   49 (35.3)
    Everolimus-eluting stent   57 (15.5) 10 (7.2)
    Biolimus-eluting stent 10 (2.7)   7 (5.0)
Mean stent diameter (mm)   3.0±0.3   3.1±0.3   0.013
Mean stent length (mm)   27.9±13.3   31.8±16.8   0.035
Post-intervention
    Reference vessel diameter (mm)   2.9±0.4   2.9±0.5   0.960
    Minimal lumen diameter (mm)   2.7±0.4   2.7±0.5   0.589
Follow-up
    Reference vessel diameter (mm)   2.8±0.4   2.7±0.5   0.409
    Minimal lumen diameter (mm)   2.1±0.5   1.3±0.6 <0.001
Optical coherence tomography <50% CSA stenosis ≥50% CSA stenosis p value
Overall, n 368 139
    Time interval after index procedure (months)   14.0±11.9   28.1±23.2 <0.001
    Mean neointimal thickness (µm) 245.5±89.4   617.1±188.5 <0.001
    Mean lumen CSA (mm2)   5.0±1.6   2.6±1.1 <0.001
    Mean stent CSA (mm2)   7.0±2.0   7.3±2.1   0.175
    Mean neointimal CSA (mm2)   2.1±1.0   4.7±1.6 <0.001
    Percent neointimal CSA stenosis (%) 29.5±9.6   65.0±10.4 <0.001
    Neointimal type <0.001
        Homogeneous 251 (68.2) 2 (1.4)
        Heterogeneous   52 (14.1) 7 (5.0)
        Layered   52 (14.1) 95 (68.3)
        Neoatheroma 13 (3.5) 35 (25.2)
Stent age <30 months, n  332  86
    Time interval after index procedure (months) 10.7±6.1 12.2±5.5   0.001
    Mean neointimal thickness (µm) 244.1±88.3   623.2±179.4 <0.001
    Mean lumen CSA (mm2)   5.0±1.6   2.7±1.1 <0.001
    Mean stent CSA (mm2)   7.1±2.0   7.7±2.0   0.014
    Mean neointimal CSA (mm2)   2.1±1.0   4.9±1.5 <0.001
    Percent neointimal CSA stenosis (%) 29.2±9.4   64.2±10.1 <0.001
    Neointimal type <0.001
        Homogeneous 230 (69.3)   1 (1.2)
        Heterogeneous   50 (15.1)   6 (7.0)
        Layered   48 (14.5)   77 (89.5)
        Neoatheroma   4 (1.2)   2 (2.3)
Stent age ≥30 months, n  36 53
    Time interval after index procedure (months)   43.9±10.3   53.9±17.0   0.007
    Mean neointimal thickness (µm) 259.0±98.7   607.1±203.8 <0.001
    Mean lumen CSA (mm2)   4.4±1.7   2.3±1.0 <0.001
    Mean stent CSA (mm2)   6.5±1.9   6.7±2.2   0.581
    Mean neointimal CSA (mm2)   2.0±0.8   4.5±1.7 <0.001
    Percent neointimal CSA stenosis (%)   32.8±10.8   66.3±10.7 <0.001
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brin accumulation, excessive inflammation, and in-stent neo-
atherosclerosis appeared as dark regions when assessed by 
OCT.14 Another pathologic study using specimens from di-
rectional coronary atherectomy showed that the layered pat-
tern was composed of smooth muscle cells and myxoma-
tous tissues which appeared as a hyperechoic inner layer and 
echolucent outer layer on OCT, respectively, while the het-
erogeneous pattern determined to be an organizing fibrin 
thrombus appeared as patchy and echolucent regions through-
out the layer on OCT.15 
Several in vivo OCT studies have revealed that various 
types of restenotic tissues can exist after DES implanta-
stenotic tissue after DES implantation. Two previous re-
ports that examined specimens from directional coronary 
atherectomy showed that restenotic tissue consisted of pro-
teoglycan-rich smooth muscle cells and fibrinoid tissue, 
and this was considered as an evidence of incomplete neo-
intimal healing after DES implantation.12,13
Recent advances in intravascular OCT systems made it 
possible to visualize and characterize neointimal tissue. Com-
paring histological findings from autopsy reports to morpho-
logical patterns determined by OCT,14 homogeneous regions 
derived from OCT are shown to represent smooth muscle 
cells and indicated normal neointima. In this same study, fi-
Table 2. Continued
Optical coherence tomography <50% CSA stenosis ≥50% CSA stenosis p value
    Neointimal type <0.001
        Homogeneous   21 (58.3)   1 (1.9)
        Heterogeneous   2 (5.6)   1 (1.9)
        Layered     4 (11.1)   18 (34.0)
        Neoatheroma     9 (25.0)   33 (62.3)
CSA, cross-sectional area.
Data are presented as (%) or mean±SD. 
Fig. 2. Distribution of various neointimal tissues according to the percentage of neointimal cross-sectional area stenosis (A) and time interval of optical co-
herence tomography after index procedure (B).
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was observed in one third of a total 86 DES restenotic le-
sions.4 Among the non-homogeneous types of neointima, 
the thin cap fibroatheroma-like pattern neointima was ob-
served more frequently in the early (<1 year) to the very 
tion.1-5 In 25 restenotic lesions with 12 months of median 
time after stent implantation, neointimal tissue structure was 
layered in 52%, homogeneous in 28%, and heterogeneous 
in 20%.1 In another OCT study, homogeneous neointima 
Fig. 3. Distribution of various neointimal tissues according to the percentage of neointimal cross-sectional area stenosis in lesions of stent age <30 months 
(A) and ≥30 months (B).
Table 3. Neointimal Types on Optical Coherence Tomography, Grouped by Clinical Presentations at Follow-Up
Acute coronary syndrome 
(n=14)
Stable angina 
(n=54)
Asymptomatic 
(n=350)
p value
Neointimal type <0.001
    Homogeneous 0 (0.0) 2 (3.7) 189 (54.0)
    Heterogeneous 0 (0.0) 3 (5.6)   52 (14.9)
    Layered   4 (28.6) 38 (70.4)   91 (26.0)
    Neoatheroma 10 (71.4) 11 (20.4) 18 (5.1)
Data are presented as n (%).
Table 4. Neointimal Types on Optical Coherence Tomography, Grouped by Drug-Eluting Stent
First-generation drug-eluting stent (n=219) New-generation drug-eluting stent (n=288) p value
Neointimal type <0.001
    Homogeneous 91 (41.6) 162 (56.3)
    Heterogeneous 26 (11.9)   33 (11.5)
    Layered 57 (26.0)   90 (31.3)
    Neoatheroma 45 (20.5)   3 (1.0)
Data are presented as n (%).
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qualitative assessment of OCT in entire stent was not per-
formed. Volumetric evaluation of quantitative OCT find-
ings was also not done. Comparison between DES and bare 
metal stent was not possible. Differences of target lesions 
between two groups might be coincidence. Furthermore, 
the characteristics of neointimal tissues have not yet been 
validated in histopathology studies.
In conclusion, the morphological features in DES-treated 
lesions assessed by OCT varied with the degree of neointi-
mal burden as well as the stent age. 
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p value
β-blocker 36 (75.0) 366 (79.7)   0.441
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Statin 36 (75.0) 429 (93.5) <0.001
Data are presented as n (%).
Seung-Yul Lee, et al.
Yonsei Med J   http://www.eymj.org   Volume 55   Number 4   July 2014952
11. Farb A, Sangiorgi G, Carter AJ, Walley VM, Edwards WD, 
Schwartz RS, et al. Pathology of acute and chronic coronary stent-
ing in humans. Circulation 1999;99:44-52.
12. van Beusekom HM, Saia F, Zindler JD, Lemos PA, Swager-Ten 
Hoor SL, van Leeuwen MA, et al. Drug-eluting stents show de-
layed healing: paclitaxel more pronounced than sirolimus. Eur 
Heart J 2007;28:974-9. 
13. Chieffo A, Foglieni C, Nodari RL, Briguori C, Sangiorgi G, Latib 
A, et al. Histopathology of clinical coronary restenosis in drug-
eluting versus bare metal stents. Am J Cardiol 2009;104:1660-7. 
14. Nakano M, Vorpahl M, Otsuka F, Taniwaki M, Yazdani SK, Finn 
AV, et al. Ex vivo assessment of vascular response to coronary 
stents by optical frequency domain imaging. JACC Cardiovasc 
Imaging 2012;5:71-82. 
15. Nagai H, Ishibashi-Ueda H, Fujii K. Histology of highly echolu-
cent regions in optical coherence tomography images from two 
patients with sirolimus-eluting stent restenosis. Catheter Cardio-
vasc Interv 2010;75:961-3. 
16. Yonetsu T, Kato K, Kim SJ, Xing L, Jia H, McNulty I, et al. Pre-
dictors for neoatherosclerosis: a retrospective observational study 
from the optical coherence tomography registry. Circ Cardiovasc 
Imaging 2012;5:660-6. 
parison of incidence and time course of neoatherosclerosis be-
tween bare metal stents and drug-eluting stents using optical co-
herence tomography. Am J Cardiol 2012;110:933-9. 
7. Takano M, Yamamoto M, Inami S, Murakami D, Ohba T, Seino Y, 
et al. Appearance of lipid-laden intima and neovascularization af-
ter implantation of bare-metal stents extended late-phase observa-
tion by intracoronary optical coherence tomography. J Am Coll 
Cardiol 2009;55:26-32.
8. Kim U, Kim JS, Kim JS, Lee JM, Son JW, Kim J, et al. The initial 
extent of malapposition in ST-elevation myocardial infarction 
treated with drug-eluting stent: the usefulness of optical coherence 
tomography. Yonsei Med J 2010;51:332-8. 
9. Prati F, Regar E, Mintz GS, Arbustini E, Di Mario C, Jang IK, et 
al. Expert review document on methodology, terminology, and 
clinical applications of optical coherence tomography: physical 
principles, methodology of image acquisition, and clinical appli-
cation for assessment of coronary arteries and atherosclerosis. Eur 
Heart J 2010;31:401-15. 
10. Lee SY, Shin DH, Mintz GS, Kim JS, Kim BK, Ko YG, et al. Op-
tical coherence tomography-based evaluation of in-stent neoath-
erosclerosis in lesions with more than 50% neointimal cross-sec-
tional area stenosis. EuroIntervention 2013;9:945-51.
